Phase III Study Evaluating Induction Chemotherapy Followed by Chemoradiotherapy Compared to Standard Chemoradiotherapy for Locally Advanced SCCA

NCT06207981 · clinicaltrials.gov ↗

PHASE3

Phase

RECRUITING

Status

310

Enrollment

OTHER

Sponsor class

Conditions

Anal Cancer

Interventions

DRUG: induction chemotherapy (mDCF)
DRUG: Concomitant chemotherapy (Capecitabin + Mitomycin-C)
RADIATION: radiotherapy

Sponsor

Federation Francophone de Cancerologie Digestive

Collaborators

[object Object]